Switching to tirzepatide linked to additional reduction in HbA1c, weight loss compared with escalating dulaglutide. (HealthDay News) — For patients with inadequately controlled type 2 diabetes ...
Early last month, medical records company Epic found a curious relationship lurking within the charts of individuals taking weight loss drugs like Ozempic and Mounjaro. Diabetics, for whom these drugs ...
Please provide your email address to receive an email when new articles are posted on . Adults with type 2 diabetes had larger decreases in HbA1c at 28 weeks with mazdutide vs. dulaglutide. More than ...
Tirzepatide is noninferior to dulaglutide with respect to a composite of death from cardiovascular (CV) causes, myocardial infarction, or stroke among patients with type 2 diabetes and atherosclerotic ...
Patients with poorly controlled type 2 diabetes despite being on dulaglutide had better outcomes if they switched to tirzepatide than if they upped their dulaglutide dose. In this randomized trial, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results